Bimekizumab ‘preferred’ option when new psoriasis biologic needed
Bimekizumab exhibited superior drug survival rates among patients with psoriasis who have previously stopped responding to at least one biologic, […]
Bimekizumab exhibited superior drug survival rates among patients with psoriasis who have previously stopped responding to at least one biologic, […]
The second season of the Emmy-award winning hospital drama “The Pitt” premieres Jan. 8 on HBO Max.The series is a
This year’s top health trend will be the expanded use of GLP-1 receptor agonists to treat chronic disease, according to
Active rash, interstitial lung disease and elevated neutrophil to lymphocyte ratio were independently associated with in-hospital mortality among patients with
Lewiss on Lifestyle MedicineThe U.S. physical activity guidelines recommend that healthy adults, including elderly, get at least 150 minutes of
Joan-Marie Stiglich, ELS, who has been with The Wyanoke Group for 31 years, will oversee Healio AI in the newly-created
On July 30, the FDA approved the first device of its kind — a vagal nerve stimulator for adults with
CHICAGO — Neuroimmune modulation could be an “emerging therapeutic approach” for patients with rheumatoid arthritis who had incomplete response or
JAK inhibitor treatment is not associated with stunted growth in children with common inflammatory diseases, according to a research letter
As physicians across specialties encounter increasing patient interest in GLP-1 receptor agonists, it is important for them to learn about
The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized
Enhanced premium tax credits, which have made Affordable Care Act coverage more accessible, will likely expire at the end of
A novel triple receptor agonist conferred weight loss of up to 28.7% at 68 weeks and reductions in pain for
Ambient listening documentation may soon become integral to clinical practice as AI advances reshape care delivery.Ambient scribes are poised to
Several changes in the 2026 Medicare Physicians Fee Schedule, or PFS, will help to better support primary, preventive and comprehensive
About one in eight adults say they are taking a GLP-1 receptor agonist as a treatment for obesity, diabetes or
I am here to tell you something that we do not discuss outside the walls of Healio and the parent
CHICAGO — Vagus nerve-mediated neuroimmune modulation by electrical stimulation using an implantable device was well-tolerated and had durable efficacy through
CHICAGO — Citrullinated protein-targeted chimeric antigen receptor regulatory T cells showed a promising safety profile in highly refractory patients with
SAN DIEGO — Forty-three percent of medical residents report using generative AI-based tools daily, but many expressed concerns about overreliance
Bruton’s tyrosine kinase inhibitors such as ibrutinib have significantly improved outcomes for chronic lymphocytic leukemia, but they can cause long-term
SAN DIEGO — Visual intelligence and collaborative AI approaches may advance health care, according to a keynote speaker at AIMed25.“Our
CHICAGO — Clinicians are increasingly concerned that AI will replace them, but experts said that this focus should shift towards
Many patients benefit from accessing their digital clinical notes, but significant disparities exist among groups that look at them.Black and
The winter holidays are imminently approaching. Gathering times like these are associated with rituals around food, beverages and gifts —
The design of hospital patient portals may prevent millions of people with limited English proficiency from fully participating in their
DALLAS — Results presented here showed patella resurfacing during total knee arthroplasty may not improve outcomes in patients with inflammatory